Effect of Different Approaches to Antimicrobial Therapy with Cefmetazole and Meropenem on the Time to Defervescence in Non-Severe Extended-Spectrum β-Lactamase-Producing <i>Escherichia coli</i> Bacteremia

• Main Authors: Takanobu Hoshi (Author), Satoshi Fujii (Author), Kei Watanabe (Author), Yuta Fukumura (Author), Koji Miyazaki (Author), Madoka Takahashi (Author), Sakae Taniguchi (Author), Shingo Kimura (Author), Arisa Saito (Author), Naoki Wada (Author), Masaji Saijo (Author), Kazunori Yamada (Author), Kuninori Iwayama (Author), Marie Itaya (Author), Hideki Sato (Author)
• Format: Book
• Published: MDPI AG, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Carbapenems are antimicrobial agents commonly used to treat extended-spectrum β-lactamase (ESBL)-producing bacteria. Although cefmetazole (CMZ) is considered effective for ESBL-producing <i>Escherichia coli</i> (ESBL-EC) bacteremia, previous studies showed its limitations, including the...